Expert Review of Precision Medicine and Drug Development (ERPMDD)

Expert Review of Precision Medicine and Drug Development [e-ISSN 2380-8993] is an international open access journal publishing rigorously peer-reviewed review articles and original papers on the development and clinical application of medicine to be used in a personalised therapy setting. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, Expert Review of Precision Medicine and Drug Development supports the necessity to identify patients responsive to treatments and treat patient populations using a tailored approach. Articles focus on the following key areas: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this; Clinical trials within personalised therapy and drug development; Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment; Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies; Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.

Expert Review of Precision Medicine and Drug Development (ERPMDD) is :-

• International, Peer-Reviewed, Open Access, Refereed, drug development, prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics, microbiomics on treatment , Online , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2380-8993, Established: 2016, Impact Factor: 1.0
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE